We are live on
!
Find out more
Fidelity International Portfolio holdings
AUM
$129B
1-Year Est. Return
30.83%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+30.83%
3 Year Est. Return
+84.29%
5 Year Est. Return
+110%
10 Year Est. Return
+535.69%
AUM
$127B
AUM Growth
+$10.2B
(+8.7%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
21.68%
Holding
1,063
New
98
Increased
423
Reduced
381
Closed
73
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$607M |
| 2 |
Scotiabank
BNS
|
+$593M |
| 3 |
Canadian National Railway
CNI
|
+$560M |
| 4 |
Applied Materials
AMAT
|
+$511M |
| 5 |
Bank of Montreal
BMO
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ANSS
Ansys
ANSS
|
+$973M |
| 2 |
Western Digital
WDC
|
+$782M |
| 3 |
Thomson Reuters
TRI
|
+$725M |
| 4 |
Lam Research
LRCX
|
+$600M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.42% |
| 2 | Financials | 18.2% |
| 3 | Industrials | 10.47% |
| 4 | Materials | 8.78% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Tandem Diabetes Care
TNDM
$1.27B
| – | – |
-191,417
| Closed | -$3.57M |
|
|
VIGL
1052
DELISTED
Vigil Neuroscience
VIGL
| – | – |
-558,762
| Closed | -$4.44M |
|
|
WBA
1053
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-20,609,000
| Closed | -$237M |
|
|
ZEPP
1054
Zepp Health
ZEPP
$63.8M
| – | – |
-704,254
| Closed | -$1.91M |
|
1055
Amer Sports
AS
$21B
| – | – |
-1,355,000
| Closed | -$52.5M |
|
1056
Hafnia
HAFN
$3.79B
| – | – |
-1,314,405
| Closed | -$6.6M |
|
|
LIF
1057
Life360
LIF
$4.48B
| – | – |
-146,073
| Closed | -$9.53M |
|
|
NBIS
1058
Nebius Group N.V.
NBIS
$37.6B
| $0 | ﹤0.01% |
12,733
| – | – |
|
|
RAL
1059
Ralliant Corp
RAL
$7.5B
| – | – |
-70,572
| Closed | -$3.42M |
|
Similar funds
Fidelity International's Q3 2025 Portfolio in Review
As of Q3 2025, Fidelity International held 1,063 positions worth $127B, up 8.7% from $117B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Fidelity International's Q3 2025 filing shows 98 new, 423 increased, 381 reduced and 73 closed positions. Its largest new stake was Verona Pharma: 3,488,500 shares worth $372M. The largest sale was Ansys, an estimated $973M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 27% a quarter earlier, followed by Financials and Industrials.
- Fidelity International's largest Q3 2025 buy was Verona Pharma: 3,488,500 shares worth $372M.
- Fidelity International added most to Synopsys in Q3 2025, an estimated $607M increase.
- Fidelity International's biggest Q3 2025 reduction was Western Digital, cutting an estimated $782M.
- Fidelity International fully exited Ansys in Q3 2025, selling an estimated $973M.
- Fidelity International's ten largest holdings make up 22% of its $127B portfolio in Q3 2025.
- Fidelity International opened 98 new positions and closed 73 in Q3 2025.
- Fidelity International's portfolio value rose 8.7% quarter-over-quarter to $127B.
Based on Fidelity International's 13F filing for Q3 2025, filed 13 Nov 2025.